Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study
Pharm. pract. (Granada, Internet)
; 19(4)oct.- dec. 2021. tab
Article
in English
| IBECS
| ID: ibc-225589
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Background:
Intravenous indomethacin has been used in infants for many years as the pharmacological closure of ductus arteriosus, but the incidence, risk, and risk factors of acute kidney injury (AKI) among infants treated with indomethacin, were still scarce.Objectives:
To determine the incidence, risk, and risk factors of AKI among infants treated with indomethacin (exposed group) for patent ductus arteriosus (PDA) closure compared with the matched non-exposed infants.Methods:
A matched retrospective cohort study of infants admitted to the neonatal intensive care unit of Songklanagarind Hospital from January 2003 to December 2018 was performed. All data were collected from computerized medical records. A non-exposed infant was matched (11) by gestational age and birth weight to each exposed infant. AKI, the outcome of interest, was diagnosed according to neonatal AKI definitions. The incidence (95% CI) of AKI was estimated for each group. Conditional logistic regression was used to estimate the odds ratio (OR) of developing AKI among those who received indomethacin compared with those who did not, adjusted for potential confounders (concomitantly used nephrotoxic potential medications including aminoglycosides, amphotericin B, vancomycin, furosemide, systemic corticosteroids, and systemic vasopressors and inotropes). Kaplan-Meier estimate was performed to examine probability of recovery from AKI after AKI events.Results:
The matching resulted in 193 pairs of exposed and non-exposed infants. The incidences [95% CI] of AKI in the exposed and the non-exposed group, were 33.7% [27.0%40.4%] and 15.5% [10.4%20.7%], respectively. Indomethacin statistically increased the risk for developing (AU)
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Indomethacin
/
Ductus Arteriosus, Patent
/
Renal Insufficiency
/
Acute Kidney Injury
Limits:
Female
/
Humans
/
Infant
/
Male
/
Infant, Newborn
Language:
English
Journal:
Pharm. pract. (Granada, Internet)
Year:
2021
Document type:
Article
Institution/Affiliation country:
Prince of Songkla University/Thailand
/
Suratthani Hospita/Thailand